{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:58:17Z","timestamp":1780469897586,"version":"3.54.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1136\/ard.62.8.771","type":"journal-article","created":{"date-parts":[[2003,7,14]],"date-time":"2003-07-14T18:50:34Z","timestamp":1058208634000},"page":"771-774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Antiphospholipid antibody in localised scleroderma"],"prefix":"10.1016","volume":"62","author":[{"given":"S","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.62.8.771_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0190-9622(94)70217-9","article-title":"Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma","volume":"31","author":"Sato","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1136\/ard.62.8.771_bib2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/art.1780360815","article-title":"Antihistone antibodies in patients with localized scleroderma","volume":"36","author":"Sato","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.62.8.771_bib3","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/archderm.1994.01690100057009","article-title":"Antigen specificity of antihistone antibodies in localized scleroderma","volume":"130","author":"Sato","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1136\/ard.62.8.771_bib4","first-page":"1083","article-title":"High prevalence of antiphospholipid antibodies in patients taking procainamide","volume":"24","author":"Merrill","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.62.8.771_bib5","first-page":"200","article-title":"Is there a phospholipid specificity of lupus anticoagulants (LAC) in patients with autoimmune and drug induced LAC?","volume":"25","author":"Hess","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.62.8.771_bib6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ajh.2830270408","article-title":"Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis","volume":"27","author":"Canoso","year":"1988","journal-title":"Am J Hematol"},{"key":"10.1136\/ard.62.8.771_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.62.8.771_bib8","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.62.8.771_bib9","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1055\/s-0038-1649901","article-title":"Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH","volume":"74","author":"Brandt","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1136\/ard.62.8.771_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/08916930109008045","article-title":"Anti-endothelial cell antibodies (AECA) in systemic sclerosis- increased sensitivity using different endothelial cell substrates and association with other autoantibodies","volume":"33","author":"Renaudineau","year":"2001","journal-title":"Autoimmunity"},{"key":"10.1136\/ard.62.8.771_bib11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2133.1988.tb03263.x","article-title":"Failure to demonstrate the lupus anticoagulant in systemic sclerosis","volume":"119","author":"Rowell","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1136\/ard.62.8.771_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0065-2776(08)60641-0","article-title":"Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology","volume":"44","author":"Tan","year":"1989","journal-title":"Adv Immunol"},{"key":"10.1136\/ard.62.8.771_bib13","first-page":"1926","article-title":"Lupus anticoagulant in drug-induced systemic lupus erythematosus (SLE)","volume":"145","author":"Gastineau","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.62.8.771_bib14","first-page":"290","article-title":"Phospholipid specificity of autoimmune and drug induced lupus anticoagulants; association of phosphatidylethanolamine reactivity with thrombosis in autoimmune disease","volume":"25","author":"Drouvalakis","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.62.8.771_bib15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/096120339700600508","article-title":"Association between IgM anticardiolipin antibodies and deep venous thrombosis in patients without systemic lupus erythematosus","volume":"6","author":"Oger","year":"1997","journal-title":"Lupus"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724089234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724089234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.62.8.771","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T07:48:57Z","timestamp":1737445737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724089234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["S0003496724089234"],"URL":"https:\/\/doi.org\/10.1136\/ard.62.8.771","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2003,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiphospholipid antibody in localised scleroderma","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.62.8.771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Copyright 2003 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}